-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2017 to 2021.
- BioXcel Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2022 was $77K, a 18.5% increase year-over-year.
- BioXcel Therapeutics, Inc. Depreciation, Depletion and Amortization for the twelve months ending March 31, 2022 was $309K, a 50% increase year-over-year.
- BioXcel Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $297K, a 58% increase from 2020.
- BioXcel Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2020 was $188K, a 20.5% increase from 2019.
- BioXcel Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2019 was $156K, a 818% increase from 2018.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)